Cyclooxygenase inhibitors and the antiplatelet effects of aspirin - Wikidata - wikimedia - TriplyDB

Cyclooxygenase inhibitors and the antiplatelet effects of aspirin

Cyclooxygenase inhibitors and the antiplatelet effects of aspirin

http://www.wikidata.org/entity/Q28191912

about

sameAs

Cardiovascular risk with non-steroidal anti-inflammatory drugs: systematic review of population-based controlled observational studies Antiplatelet resistance in stroke Drug Resistance and Pseudoresistance: An Unintended Consequence of Enteric Coating Aspirin Antiplatelet and anticoagulant agents for preventing recurrence of peripheral vascular thrombosis in patients with Antiphospholipid syndrome Determinants of the cellular specificity of acetaminophen as an inhibitor of prostaglandin H(2) synthases.Drug interactions--principles, examples and clinical consequences A turbulent decade for NSAIDs: update on current concepts of classification, epidemiology, comparative efficacy, and toxicity Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials Taking the stress out of managing gout The antithrombotic profile of aspirin. Aspirin resistance, or simply failure?COX-2: Where are we in 2003? - Be strong and resolute: continue to use COX-2 selective inhibitors at recommended dosages in appropriate patients COX-2: where are we in 2003?--distinction from NSAIDs becoming blurred Effect of paracetamol (acetaminophen) and ibuprofen on body temperature in acute ischemic stroke PISA, a phase II double-blind, randomized, placebo-controlled trial [ISRCTN98608690]Long-term use of non-steroidal anti-inflammatory drugs and the risk of myocardial infarction in the general population Prime Drug Interplay in Dental Practice Adverse drug reactions and drug-drug interactions with over-the-counter NSAIDs Impairment of aspirin antiplatelet effects by non-opioid analgesic medication Testing cardiovascular drug safety and efficacy in randomized trials Aspirin resistance: current status and role of tailored therapy New insights into the use of currently available non-steroidal anti-inflammatory drugs Variability in the response to non-steroidal anti-inflammatory drugs: mechanisms and perspectives Mitigating the cardiovascular and renal effects of NSAIDs Coxibs interfere with the action of aspirin by binding tightly to one monomer of cyclooxygenase-1 Mass spectrometry-based approaches to targeted quantitative proteomics in cardiovascular disease Relationship of arachidonic acid concentration to cyclooxygenase-dependent human platelet aggregation Giving aspirin and ibuprofen after myocardial infarction Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications--review and recommendations based on risk assessment NSAIDs: gastroprotection or selective COX-2 inhibitor?Meloxicam does not affect the antiplatelet effect of aspirin in healthy male and female volunteers Interactions between aspirin and COX-2 inhibitors or NSAIDs in a rat thrombosis model Impact of nonsteroidal antiinflammatory drugs on the cardioprotective effects of aspirin The cardiovascular toxicity of selective and nonselective cyclooxygenase inhibitors: comparisons, contrasts, and aspirin confounding Current use of nonsteroidal antiinflammatory drugs and the risk of acute myocardial infarction Aspirin resistance: an evaluation of current evidence and measurement methods Therapeutic approaches in arterial thrombosis Determinants of the interindividual variability in response to antiplatelet drugs Aspirin resistance Cardiovascular and gastrointestinal effects of COX-2 inhibitors and NSAIDs: achieving a balance Lumiracoxib does not affect the ex vivo antiplatelet aggregation activity of low-dose aspirin in healthy subjects Resistance to antiplatelet drugs: current status and future research

P2860

Q21144617-9C325D05-01CB-4E91-ADB6-4C157FFCA520 Q22305927-B7C0C973-59EE-4102-A43C-294E11B0CD3F Q22306342-09647B9F-CB7E-4D76-863E-12446AD9D9D9 Q24185813-A888E97B-F5E1-4F99-AF71-26DCCE0BED01 Q24531388-4123CCF4-DED7-4938-8A3C-05FE4FB09EE8 Q24599421-F2B8F0AD-F850-416C-88F6-855B7E3E03B1 Q24615651-A2C58F50-D019-48E8-88B3-99E841650F03 Q24619410-2F0FC78F-EF2B-4633-9801-71A25BB6E4CF Q24658037-F461A05F-7120-441D-8DC6-726CC22A12BB Q24794673-62617A94-9FC9-4B01-A6DA-36187D2ACB94 Q24796193-8256438A-BD70-44B5-BB12-AAD9394C8204 Q24804373-DD549ACB-7931-4680-8B6D-E2A0287B26E9 Q24806469-B6C781B3-F2E8-43DC-964F-D552DCB75197 Q24816136-0EC20D7F-1708-4D08-A107-775D562AF3CB Q26748474-76C66ED5-712D-407C-B223-02DC1EE9E7B6 Q26800279-36470E7C-ADA7-4AFD-A8C0-02891F50C9D9 Q26801633-271C6DE2-5BC8-44DB-B3FA-BEBCFE175C3E Q26849771-E6FB96D3-43A1-405B-B9B1-7E7FF3D34A14 Q26851367-77140CC2-1252-45CD-B083-90D8699D5BB1 Q26852330-3D102103-CF83-4291-B0F4-9C99E8B6B355 Q27012539-B12124EC-86FC-430A-9573-99096D746EA6 Q27022837-477135BB-D147-4219-B25B-FA053BAB30C8 Q27658412-AE03F28C-62C9-40DE-8ED0-AB3D3EE451EC Q28075372-4549A70F-88C2-44B8-8390-C48281086A9F Q28165301-6C5EFC1E-1750-42B3-99A7-2CF2C36A6F85 Q28166360-DB637919-1F92-4FE4-A187-8B885C86B858 Q28168612-39F6D0DD-A381-48C9-A86D-81E8A63B4A82 Q28168965-C319E1E4-716E-4410-A53D-8D262D745D36 Q28168971-17E05FC3-0585-4D7A-9387-EA88BDD32E5F Q28171150-709D97F8-7380-4605-895B-08F54D28AC50 Q28174778-8901DB64-7476-4EE0-B17E-392FA60EB62C Q28177082-3BF12B36-5E4D-4DF3-A6D2-6A7F11DEE0B2 Q28181807-CC9022C5-1701-47B2-BF71-8B9671A978E3 Q28183220-67F05468-FAF0-4814-B6C2-B348F678CDA6 Q28187576-1D4EA7B6-2B7D-45B1-9911-DB63826A1F08 Q28187591-D8B44E5C-E4E4-45D5-999C-23A1ABC46F4D Q28187611-C9C50083-449D-4B86-86B8-A6F54F8A74A3 Q28191924-158C829B-A4F5-4D3A-8A21-7E8C9AB708E4 Q28192026-2E5ED4DF-72EB-4806-9F9B-74C5D43CAE9B Q28192298-ABED5050-3229-42CA-8DEF-B0C58E5CA1A6

P2860

Cyclooxygenase inhibitors and the antiplatelet effects of aspirin

http://www.wikidata.org/entity/Q28191912

description

2001 nî lūn-bûn

@nan

2001 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Cyclooxygenase inhibitors and the antiplatelet effects of aspirin

@ast

Cyclooxygenase inhibitors and the antiplatelet effects of aspirin

@en

Cyclooxygenase inhibitors and the antiplatelet effects of aspirin

@nl

type

label

Cyclooxygenase inhibitors and the antiplatelet effects of aspirin

@ast

Cyclooxygenase inhibitors and the antiplatelet effects of aspirin

@en

Cyclooxygenase inhibitors and the antiplatelet effects of aspirin

@nl

prefLabel

Cyclooxygenase inhibitors and the antiplatelet effects of aspirin

@ast

Cyclooxygenase inhibitors and the antiplatelet effects of aspirin

@en

Cyclooxygenase inhibitors and the antiplatelet effects of aspirin

@nl

P1433

Q28191912-251B6C3C-A8F5-44FD-AAA8-22CD4E47ADFC

P1476

Q28191912-975292B1-55B8-47D4-BA15-CFDBF5EEF591

P2093

Q28191912-655EEB57-FF0D-4F9B-8A1D-81D94347E0CC

Q28191912-7959038E-D1C4-4037-AB77-27C1018392D7

Q28191912-B30F714A-8973-4A8E-9152-9F0A0ADDFFB0

Q28191912-C33587D7-071C-4F18-83A2-F710D329AC22

Q28191912-C7A675AF-632A-4D40-8740-E1AC5B542BFA

Q28191912-CD47664F-DB94-478A-BAFF-4BCC373819E8

Q28191912-DC3A378B-A224-4595-AB42-16CABC672840

P304

Q28191912-D0177629-7E0F-470A-B6FF-EDAA5513C098

P31

Q28191912-00EE0A06-92A4-4652-960F-6C5444234BE0

P3181

Q28191912-CE0EA53E-A991-4694-B42F-BFE87378F60B

P356

Q28191912-D307537C-264C-431D-9D99-A934972F94FD

P407

Q28191912-830AC437-C956-45FC-98BD-CF24C252CCB9

P433

Q28191912-ADE37E96-920E-4860-B2D3-0911AFDF41D2

P478

Q28191912-95EAE5B8-0175-4BF7-8EFA-AD8EDDAA1182

P50

Q28191912-17149F73-D303-48DB-9BEB-17315970A0D7

P577

Q28191912-AC62728A-756D-4991-AA50-5F99078C22B6

P5875

Q28191912-E2EA6CD8-EC0E-4C29-9A6B-C570F022CC8E

P698

Q28191912-6412D628-E662-4209-B3A9-78C5306BFB34

P921

Q28191912-8C6B7C77-47F7-4A7E-AE32-6FD2B320D347

P3181

P356

P1433

The New England Journal of Medicine

P1476

Cyclooxygenase inhibitors and the antiplatelet effects of aspirin

@en

P2093

A J Cucchiara

http://www.w3.org/2001/XMLSchema#string

B Tournier

http://www.w3.org/2001/XMLSchema#string

F Catella-Lawson

http://www.w3.org/2001/XMLSchema#string

G A FitzGerald

http://www.w3.org/2001/XMLSchema#string

S C Kapoor

http://www.w3.org/2001/XMLSchema#string

S DeMarco

http://www.w3.org/2001/XMLSchema#string

S N Vyas

http://www.w3.org/2001/XMLSchema#string

P304

1809-1817

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3131598

http://www.w3.org/2001/XMLSchema#string

P356

10.1056/NEJMOA003199

http://www.w3.org/2001/XMLSchema#string

P407

P433

25

http://www.w3.org/2001/XMLSchema#string

P478

345

http://www.w3.org/2001/XMLSchema#string

P50

Muredach P. Reilly

P577

2001-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11605681

http://www.w3.org/2001/XMLSchema#string

P698

11752357

http://www.w3.org/2001/XMLSchema#string

P921